{
    "2018-07-10": [
        [
            {
                "time": "",
                "original_text": "药明康德、宁德时代之后，又一巨头迈瑞医疗冲刺A股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "宁德时代",
                        "迈瑞医疗",
                        "A股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗设备",
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[看好评级]医药生物行业2018年中报业绩前瞻：医疗需求刚性 重点关注稳健成长和“流量入口”型公司",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中报业绩",
                        "医疗需求",
                        "稳健成长",
                        "流量入口"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]医药生物行业7月月报：调整中布局下半年行情",
                "features": {
                    "keywords": [
                        "医药生物",
                        "买入评级",
                        "调整",
                        "下半年行情"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：市场或迎来中级反弹 防御为先医药为上",
                "features": {
                    "keywords": [
                        "医药生物",
                        "增持评级",
                        "中级反弹",
                        "防御"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业卓越推：华兰生物(002007)、天坛生物(600161)",
                "features": {
                    "keywords": [
                        "医药行业",
                        "华兰生物",
                        "天坛生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]医药生物行业2018年中报业绩前瞻：重点覆盖公司中报业绩前瞻：关注2季度增速加快个股",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中报业绩",
                        "推荐评级",
                        "2季度增速"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上半年业绩暴增股备受资金青睐 三股同比增幅超前",
                "features": {
                    "keywords": [
                        "上半年业绩",
                        "暴增股",
                        "资金青睐",
                        "同比增幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]医药行业周报：布局政策免疫品种 推荐二线细分龙头",
                "features": {
                    "keywords": [
                        "医药行业",
                        "推荐评级",
                        "政策免疫",
                        "二线细分龙头"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报:《我不是药神》引热议,持续看好创新药板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "我不是药神",
                        "创新药板块"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物",
                        "创新药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}